Delivery Order SPE2DB20D1109-SPE2DB24FP90D
Award Date
9/12/24
Potential Completion Date
10/3/24
Potential Value
$16K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Xeomin (50 unit vials) medical products. The contract is a firm fixed-price, non-set-aside award with a ceiling value of $10,941.84 and a performance period extending to May 1, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which...
This is a $3,145.44 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) for the supply of Xeomin 100 unit vials. The order has an ultimate completion date of October 1, 2024 and was awarded on September 10, 2024. This delivery order is issued under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which has a ceiling value of up to $999,999,999 and runs through December 2025. The IDC enables the DLA to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 200-unit vials of the drug Xeomin. The contract has a firm fixed price of $6,155.52 and a completion date of January 18, 2023. The award is not designated as a set-aside contract. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 50-unit vials of the drug Xeomin. The contract, valued at $1,710.00, is a Firm Fixed Price delivery order with an ultimate completion date of August 19, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 4,565,214,300 units of the drug XEOMIN in 200-unit vials. The contract, valued at $10,485.00, has a firm fixed price and a completion date of August 9, 2024. This order is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, to...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of XEOMIN 200 unit vials. The firm-fixed-price contract has a ceiling value of $3,145.50 and an ultimate completion date of November 19, 2024. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Xeomin 100 UT Vial 1S, a medical product, with a ceiling value of $5,587.40. The contract is a firm fixed-price delivery order, with a period of performance through May 19, 2025. This contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a larger Indefinite...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor, for the supply of 4,567,971,896 vials of XEOMIN 100 unit. The contract is a firm fixed-price delivery order with a ceiling value of $3,352.44 and a performance period through May 8, 2025. The contract is not set aside for any specific business category. AmerisourceBergen Drug Corporation holds a significant Indefinite Delivery Contract (IDC) with the...
This is a Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of XEOMIN 200 unit vials. The award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract has a ceiling value of...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $16,762.20, is for the delivery of 200-unit vials of the drug XEOMIN. The contract is a firm fixed price, delivery order contract with a performance period ending on March 31, 2025. This contract award is not associated with a set-aside program and is part of AmerisourceBergen's larger...